Investors are pricing in significant future growth
Posey EA, He WL, Wu G
What This GLP-1 Cluster Explains Across this series, youll learn: how GLP-1 works within enteroendocrine and gutbrain signaling why microbiome damage weakens GLP-1 sensitivity how stress and cortisol disrupt appetite regulation how SCFAs restore metabolic flexibility what GLP-1 medications cannot biologically repair Whether GLP-1 medications are used or not, long-term metabolic outcomes depend on the same foundation : A stable microbiome that produces adequate SCFAs and supports natural GLP-1 signaling
Methods This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify and evaluate in vitro studies investigating the effects of glucagon-like peptide-1 receptor agonists and their analogues on human mesenchymal stem cell functions, including proliferation, differentiation, signaling, apoptosis, and tissue-specific applications
Beyond their role in addiction, GLP-1 receptor agonists are used in a range of medical conditions, including type 2 diabetes, obesity, cardiovascular disease, liver and kidney health, and emerging research in neurodegenerative disorders